Review of the San Francisco Money Show: Recommended Stocks

I was privileged to give a couple of presentations at the San Francisco Money Show on the stock trading technique of 'buying dividends' during the last couple days, and had a very good turnout and much positive feedback.

The show was held at the San Francisco Marriott Marquis Hotel on August 19th through August 21. The keynote speaker was Steve Forbes, Editor-in-Chief of Forbes Magazine, who spoke very candidly about his opinion of the current administration and its policies adversely affecting the economy and the stock market. However, he was positive about the future and expects many favorable changes to take place over the next couple of years. He went into detail about how capitalism and the free market can save the economy, even with health care, Social Security, and Medicare. His latest book has recently been published, How Capitalism Will Save Us: Why Free People and Free Markets Are the Best Answer in Today's Economy.

The Opening Ceremonies panel discussion was on Nanotech, with four panelists discussing the various aspects of this fast growing industry, and how nanotechnology is used in heathcare, technology, batteries, transportation (boats with nanotech hulls), and many other areas.

Some of the stocks that were mentioned in this industry include Harris and Harris Group (TINY), the stock with the great stock ticker symbol, a venture capital company which specializes in early stage nanotechnology companies. Other companies mentioned were Nanosphere (NSPH), Starpharma (SPHRY.PK), A123 Systems (AONE), Cree (CREE), First Solar (FSLR), and SunPower (SPWRA).

There were 55 seminars to choose from on Thursday, 99 on Friday, and 24 on Saturday, covering everything from options, to ADR's, to ETF's, to dividends, to low priced stocks, to China stocks, to numerous other topics.

One interesting one was called The Top Ten ETFs and Stocks You Should Buy Now, with Mark Skousen and Doug Fabian. Skousen mentioned Enterprise Products Partners (EPD) due to its rising dividend, currently yielding 6%, and insider buying. He also recommended Ford (F), due to the fact that sales are rising substantially, the early paydown of debt, and a forward PE of 10.

Fabian recommended iShares S&P Global Telecom ETF (IXP) due to its 4.8% yield, paid quarterly. He also likes PowerShares CEF Income Composite (PCEF), which invests in master limited partnerships but doesn't issue K-1s. It pays an 8.5% yield.

Another informative speaker was Michael Murphy who's presentation was called 'Best Tech and Biotech Stocks for the Next Ten Years.' In the Content on Demand sector, he likes TowerStream Corporation (TWER), a company that puts wireless towers on buildings and offers broadband services to businesses. The company has already signed up eleven cities. Insiders own 30% of the company.

In the biotech arena, one of the stock he recommends is Rochester Medical Corp. (ROCM), which makes catheters made of silicone instead of latex, to avoid the latex allergies for some patients. This also allows the use of anti-fungals in the catheters.

One stock he favors in the energy sector is Connacher Oil (CLL.TO), a Canadian company that is in the oil sands industry. Murphy also likes the geothermal industry due to the very favorable government tax credits and loans available to developing projects.

If you missed the MoneyShow in San Francisco, you can check out other upcoming MoneyShows at MoneyShow.com. And if you want to find more information on buying dividends, check out our recent article on stocks going ex dividend.

Author owns F.

By Stockerblog.comMarket News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Alternative CarriersAsset Management & Custody BanksAutomobile ManufacturersBiotechnologyConsumer DiscretionaryElectrical Components & EquipmentEnergyFinancialsHealth CareHealth Care SuppliesIndustrialsInformation TechnologyOil & Gas Storage & TransportationSemiconductorsTelecommunication Services
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!